Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1634239

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1634239

Global Effervescent Tablet Market - 2024 - 2031

PUBLISHED:
PAGES: 159 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4350
PDF & Excel (Multiple User License)
USD 4850
PDF & Excel (Enterprise License)
USD 7850

Add to Cart

Global Effervescent Tablet Market reached US$ 9.98 billion in 2023 and is expected to reach US$ 20.13 billion by 2031, growing with a CAGR of 9.17% during the forecast period 2024-2031.

Effervescent tablets are manufactured by compressing effervescent granules composed of citric acid and sodium bicarbonate. When these tablets are immersed in water, the reaction between the acid and the base generates carbon dioxide, manifesting as gas bubbles in the liquid. The rapid disintegration of these tablets facilitates swift dissolving and absorption.

The market share of effervescent tablets is influenced by multiple variables that enhance their appeal and expansion across numerous sectors, including convenience, heightened demand for dietary supplements, pharmaceutical uses and the growing over-the-counter market. Excessive consumption of certain effervescent pills can lead to detrimental effects instead of therapeutic benefits, hence constraining market expansion. The industry is undergoing substantial expansion owing to various driving forces.

The rising prevalence of effervescent tablets among the elderly is a significant development, as these tablets provide convenience and facilitate intake for individuals with mobility challenges or difficulties in swallowing solid forms. The proliferation of effervescent supplements for youth and children is broadening the market's scope, rendering it a versatile option for many age demographics. In contrast to traditional drugs that may require extended digestion time, effervescent weight reduction supplements provide a more rapid commencement of action, hence promoting swifter outcomes in weight control endeavors.

Dynamics

Driver 1 - Growing Demand for Dietary Supplements

The rising demand for nutritional supplements is substantially propelling the effervescent tablet market as customers increasingly pursue easy, pleasant and efficacious methods to improve their health and wellness. Effervescent tablets provide rapid absorption and facilitate digestion, rendering them a favored option for health-conscious persons.

The increasing demand for vitamins, minerals and herbal supplements, especially among millennials and health aficionados, has prompted manufacturers to develop and broaden their effervescent product offerings. Moreover, the allure of effervescent formulations, frequently linked to enhanced flavor and pleasurable consumption experiences, corresponds with consumer inclinations for functional items that integrate effortlessly into their lifestyles, thereby propelling growth in this sector.

Vitamin C is a recognized dietary vitamin possessing immune-enhancing properties. Effervescent vitamin C tablets have gained popularity among customers due to their agreeable taste and convenient administration. Effervescent vitamin C tablets are favored over conventional vitamin C tablets or capsules due to their ability to dissolve in water, creating a palatable and effervescent beverage. Multivitamins are recognized nutritional supplements containing an assortment of vitamins and minerals.

Effervescent multivitamin tablets offer a comprehensive solution for fulfilling daily nutritional requirements in a convenient and enjoyable manner. The Council for Responsible Nutrition's Annual Survey on Dietary Supplements indicates that dietary supplement utilization in the US has reached a record peak. The poll indicates that 76% of individuals in the US will utilize dietary supplements, an increase from 74% the prior year. This data illustrates the increasing interest in and reliance on dietary supplements to enhance overall health and wellness. This propels the expansion of the effervescent tablet industry.

Driver 2 - Advancing Patient Compliance and Therapeutic Efficiency

The ability of effervescent tablets to enhance patient compliance, especially in patients who struggle to swallow traditional tablets, including the elderly, children and those with dysphagia, is a significant factor. This novel formulation converts medication into a tasty and easily ingestible fluid, fulfilling a significant unmet need in healthcare.

Effervescence technology has various advantages beyond simple administration. Effervescent tablets boost solubility and bioavailability by adding substantial quantities of Active Pharmaceutical Ingredients (APIs), resulting in expedited therapeutic effects with reduced gastrointestinal irritation. The fast dissolution process, driven by an acid-base reaction in an aqueous environment, illustrates their efficacy in drug administration. The characteristics render effervescent tablets especially appropriate for active pharmaceutical ingredients that are hydrophobic or unstable in certain pH conditions, thus expanding their utility across diverse therapeutic domains.

Recent innovations have enhanced the adaptability of effervescent pills. Innovations include gastro-retentive and slow-release formulations facilitate targeted medication distribution, extending residence duration in the gastrointestinal tract and minimizing dose frequency. This not only improves therapeutic results but also reduces adverse effects, hence increasing patient compliance.

Restraint: High Production Costs

The manufacturing of effervescent tablets is high due to the requirement for sophisticated production techniques and specific packaging. These pills are extremely susceptible to moisture, requiring regulated production conditions with low humidity and sealed packaging to ensure stability. The utilization of premium excipients and sophisticated formulations increases production expenses. Regulatory bodies like the FDA and EMA impose rigorous quality standards to guarantee the safety and efficacy of effervescent products, particularly in pharmaceutical and dietary supplement contexts.

Manufacturers must comply with Good Manufacturing Practices (GMP) and perform stringent testing to fulfill these standards, hence elevating operational costs. Exorbitant expenses can result in increased retail pricing, constraining accessibility in price-sensitive markets. This economic obstacle limits consumer adoption and impedes market penetration, especially in emerging areas, therefore serving as a substantial constraint on market expansion.

Segment Analysis

The global effervescent tablet market is segmented based on product type, form, packaging type, type, application, distribution channel and region.

Rising Enhanced Packaging

Aluminum and plastic tubes signify a notable improvement in packaging solutions for effervescent tablets, effectively mitigating essential issues related to moisture exposure that can negatively impact product quality. In the nutritional supplement sector, moisture can infiltrate packaging, resulting in early breakdown, color degradation, diminished efficacy or the emergence of unpleasant odors in effervescent pills.

In addition to moisture protection, the packaging design of aluminum and plastic tubes markedly improves brand visibility and consumer recognition at the point of sale. The potential for photorealistic printing enables firms to produce visually striking packaging that distinguishes itself in a saturated market.

Diverse surface textures, removable labels and cost-effective CMYK printing with a maximum of eight colors, inclusive of metallic finishes, empower businesses to convey vital product information in an appealing and clear manner. This focus on visual appeal, coupled with effective branding methods, corresponds with the growing consumer inclination towards health-oriented products, hence enhancing brand loyalty and consumer engagement.

The utilization of low-migration paints and varnishes that conform to international food safety standards highlights a dedication to safety and compliance in the packaging of effervescent tablets. By using for aluminium or plastic tubes for packaging, producers may safeguard their effervescent products from environmental influences while maintaining a professional and aesthetically pleasing presentation.

Geographical Penetration

Rising prevalence of chronic diseases in North America

The rising prevalence of chronic diseases and the presence of significant market players are ascribed to regional expansion. CDC statistics indicates that in 2020, there were 1,603,844 newly reported cancer cases in the US, along with 602,347 documented cancer-related deaths. For every 100,000 individuals, there were 403 newly diagnosed instances of cancer and 144 cancer-related fatalities. The FDA oversees dietary supplements and medications.

Dietary supplements, particularly effervescent tablets, are required to comply with FDA requirements. The FDA regulations safeguard product safety and quality, influencing market access and growth in North America. Moreover, the region's growing senior demographic and novel product launches propel market revenue.

Competitive Landscape

The major players in the market include Pfizer Inc., Novartis AG, Perrigo Company plc, Bristol-Myers Squibb Company, CHIESI SAS, Hermes Pharma, Herbalife International of America, Inc., Vovantis Laboratories, Natur Produkt Zdrovit Sp Z O O and Amerilab Technologies Inc.

Sustainability Analysis

The sustainability of the effervescent tablet market is supported by its environmentally friendly characteristics and its conformity with changing consumer and industry trends. Effervescent tablets, especially in cleaning applications, are biodegradable and eco-friendly, leaving no detrimental residues in ecosystems. Their compact, concentrated formulations diminish the necessity for unnecessary product application, therefore reducing waste and resource usage. This efficiency aligns with consumer aspirations for sustainable and economical cleaning solutions.

Innovations in packaging enhance the market's sustainability. Effervescent pills advantageously utilize the increasing transition towards bio-based and biodegradable packaging. Traditionally, the plastics sector depended significantly on fossil-derived materials; however, recent innovations have resulted in a greater utilization of renewable resources in packaging. Bio-based plastics, present in various forms since the 19th century, are seeing a resurgence, providing feasible solutions for mitigating the environmental impact of packaging.

Effervescent products also address the trend of minimizing packaging via e-commerce and subscription-based distribution models. These strategies correspond with consumer initiatives to reduce their ecological impact while maintaining convenience. The variety of effervescent tablets, which includes applications from denture cleaners to household cleaning agents, enhances their market appeal and emphasizes their contribution to sustainable consumption practices.

Consumer Behaviour Analysis

Consumer behavior regarding effervescent tablets indicates an increasing demand for alternative supplement delivery methods, as demonstrated by the surge in non-pill supplements, which currently represent approximately 34% of US supplement sales. The change is driven by consumers' inclination towards pleasurable and convenient alternatives, with formats like as candies, drink mixes and effervescent tablets becoming more favored than conventional pills. Gummy supplements have attained an impressive growth in recent years, underscoring the desire for formats that integrate functionality with an enjoyable experience.

Effervescent tablets provide a unique benefit by delivering nutrients in a palatable, carbonated beverage, attracting consumers who value flavor and convenience. These traits correspond with trends noted in other formats, where 52% of gummy consumers identify taste as the paramount characteristic, above affordability (37%) and high-quality components (25%). Effervescent pills address the demand for convenient, portable solutions that may be used without water, appealing to busy, health-conscious persons.

The increasing focus on clean-label supplements, propelled by Millennials and Gen Z, enhances the attractiveness of effervescent tablets. Consumers are progressively pursuing products containing natural ingredients, devoid of preservatives and artificial additives, hence affirming the appeal of effervescent tablets in the dynamic supplement industry.

Early Stage Innovations

Effervescent tablet formulations indicate an emerging invention with potential uses in sustained and gastro-retentive medication delivery systems. Recent developments underscore their promise in tackling critical obstacles including quick medication onset, restricted bioavailability and frequent dosage necessities. Effervescent tablets of nateglinide exhibited 99% drug release after 24 hours and maintained stability under diverse environmental conditions, addressing the limited duration of insulinotropic activity in the treatment of type II diabetes mellitus. The tablets, formulated using direct compression, employed excipients such as ethyl cellulose and Carbopol 930, with compatibility verified by FTIR and DSC analyses.

Effervescent floating tablets of fluoxetine for the treatment of depression demonstrated a 96% release within 12 hours, conforming to the Korsmeyer-Peppas release model. Their reliability is emphasized by stability under temperature and humidity fluctuations, as well as strong rheological qualities. Domperidone tablets exemplify a 98% release over 12 hours, underscoring their ability to improve medication absorption in particular gastrointestinal areas.

Effervescent formulations of silymarin flavonolignans for hepatic disorders demonstrated sustained release (95% over 16 hours), demonstrating zero-order kinetics and strong mechanical characteristics. These advances collectively highlight the potential of effervescent tablets to boost therapeutic results by improving drug delivery efficiency and patient compliance, indicating a disruptive approach in pharmaceutical research.

Emerging Market Players and Strategic Initiatives

Effervescent tablets are experiencing a renewed popularity because of changing customer preferences and innovations in manufacturing methods. Despite being generally regarded as an "old-fashioned" dosage type, their increasing market demand highlights its significance in contemporary healthcare. The global effervescent tablet market, valued at $356.3 million in 2023, is anticipated to expand at a strong CAGR of 6.8%, reaching $570.3 million by 2030. This expansion is propelled by their ease of consumption, better flavor and quick medicinal effects, which correspond with customer demands for convenience and an improved user experience.

New entrants are utilizing advanced manufacturing techniques, like TOPO granulation and unique horizontally aligned granulator technology, to enhance the stability, flavor and cost-effectiveness of effervescent tablets. These innovations facilitate accelerated production cycles, diminished carbon footprints and improved shelf life, especially in adverse climates.

Pharmaceutical companies are now strategically reintroducing effervescent tablets as luxury products, leveraging recent technology advancements. Companies are investigating novel formulations with distinctive active ingredients to address various customer categories, including the elderly and younger populations. In doing so, businesses are both broadening their product ranges and strengthening their market position in a competitive and dynamic environment.

Key Developments

  • In April 2022, Health Innovations Ltd., a UK-based maker of healthcare supplements, launched a novel EfferShield technology for effervescent pills and powders. This proprietary method has been designed to offer clients easy packaging solutions, including single-use pouches and stick packs.

Why Purchase the Report?

  • To visualize the global effervescent tablet market segmentation based on product type, form, packaging type, type, application, distribution channel and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of the effervescent tablet market with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global effervescent tablet market report would provide approximately 86 tables, 88 figures and 202 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Product Code: FB9039

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Form
  • 3.3. Snippet by Packaging Type
  • 3.4. Snippet by Type
  • 3.5. Snippet by Application
  • 3.6. Snippet by Distribution Channel
  • 3.7. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Demand for Dietary Supplements
      • 4.1.1.2. Advancing Patient Compliance and Therapeutic Efficiency
    • 4.1.2. Restraints
      • 4.1.2.1. High Production Costs
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. DMI Opinion

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Nutritional Supplements*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Pharmaceuticals
  • 6.4. Dietary Products
  • 6.5. Energy Boosters
  • 6.6. Others

7. By Form

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 7.1.2. Market Attractiveness Index, By Form
  • 7.2. Enteric Coated Tablets*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Sublingual Tablets
  • 7.4. Chewable Tablets
  • 7.5. Others

8. By Packaging Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 8.1.2. Market Attractiveness Index, By Age Group
  • 8.2. Plastic/Aluminium Tubes*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Sachets
  • 8.4. Blister Packaging
  • 8.5. Others

9. By Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.1.2. Market Attractiveness Index, By Type
  • 9.2. Prescription*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Over the counter

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Personal Care and Beauty*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Food and Beverage
  • 10.4. Sports and Fitness
  • 10.5. Marine
  • 10.6. Others

11. By Distribution Channel

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.1.2. Market Attractiveness Index, By Distribution Channel
  • 11.2. Pharmaceuticals*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Supermarkets
  • 11.4. eCommerce
  • 11.5. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.2.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.9.1. US
      • 12.2.9.2. Canada
      • 12.2.9.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.3.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.9.1. Germany
      • 12.3.9.2. UK
      • 12.3.9.3. France
      • 12.3.9.4. Italy
      • 12.3.9.5. Spain
      • 12.3.9.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.4.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.9.1. Brazil
      • 12.4.9.2. Argentina
      • 12.4.9.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.5.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.9.1. China
      • 12.5.9.2. India
      • 12.5.9.3. Japan
      • 12.5.9.4. Australia
      • 12.5.9.5. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Pfizer Inc.*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. Novartis AG
  • 14.3. Perrigo Company plc
  • 14.4. Bristol-Myers Squibb Company
  • 14.5. CHIESI SAS
  • 14.6. Hermes Pharma
  • 14.7. Herbalife International of America, Inc.
  • 14.8. Vovantis Laboratories
  • 14.9. Natur Produkt Zdrovit Sp Z O O
  • 14.10. Amerilab Technologies Inc.

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!